Evidence map›Paper›PMID 39363529›Full record

ArticleJournal of basic microbiology2024

In Vitro Antagonistic Activity of Plant Growth Promoting Rhizobacteria Against Aggressive Biotypes of the Green Mold.

Baran Mis, Kemal Karaca, Rengin Eltem

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of basic microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Baran MisDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Izmir, Turkey.ORCID http://orcid.org/0009-0001-4774-1792
Kemal KaracaDepartment of Bioengineering, Graduate School of Natural and Applied Sciences, Ege University, Izmir, Turkey.
Rengin EltemDepartment of Bioengineering, Faculty of Engineering, Ege University, Izmir, Turkey.

Funding

This work is supported by the TUBITAK (The Scientific and Technological Research Council of Turkey) 2209-B University Students Industry Oriented Research Projects Support Program (Project number: 1139B412200782).
6 · The paper itself

Abstract

During the cultivation of button mushrooms, the green mold epidemic, which causes a decrease in productivity, is a very important problem. The environmental harm of chemicals used in the control of such epidemics and the demand of consumers for organic products without chemicals have brought environmentally friendly biological control to the fore. Biological control can be achieved by the use of antagonistic microorganisms and their metabolites. In this study, the effectiveness of Bacillus spp. and Pseudomonas spp. for the biological control of the aggressive biotypes of the green mold disease agent Trichoderma aggressivum strains was examined in vitro. For this purpose, the antifungal effects of Bacillus spp. and Pseudomonas spp. against T. aggressivum strains were examined by in vitro dual culture test. Afterward, the antifungal activity of Bacillus spp. metabolites was assessed further using the agar well diffusion method. Then, it was determined whether the bacterial strains showing antifungal activity showed antagonistic activity against A. bisporus. Although none of the Pseudomonas spp. showed antifungal activity against T. aggressivum strains, most of the Bacillus spp. were found to have high activity. It has been concluded that Bacillus sp. Ö-4-82 may be potential biological control agent for button mushroom cultivation.

Indexed as

AntibiosisBacillusPseudomonasTrichodermaAgaricalesAntifungal AgentsBiological Control AgentsPlant DevelopmentAntifungal AgentsBiological Control AgentsAgaricus bisporusBacillus sppbiological controlPseudomonas sppTrichoderma aggressivum

Identifiers

PMID39363529
PMCPMC11609499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.